Risk factors for ulcerative oral mucositis in cancer patients: Unanswered questions

Oral Oncology

Volumn 39, Issue 2, 2003, Pages 91-100

  Barasch, Andrei ^a   Peterson, Douglas E ^b  

^a Univ of Connecticut Health Center ^*  (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Cancer therapy; Mucositis; Oral cavity; Pathogenesis; Risk factors

Indexed keywords

AMPHOTERICIN B; ANTINEOPLASTIC AGENT; BENZYDAMINE; BETAMETHASONE; BUSULFAN; CHLORHEXIDINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR; ETOPOSIDE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; KERATINOCYTE GROWTH FACTOR; POLYMYXIN; PROPANTHELINE BROMIDE; THIOTEPA; TOBRAMYCIN; TRANSFORMING GROWTH FACTOR BETA3;

AGE; ANEMIA; BLEEDING; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL RESEARCH; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; HISTORY; HUMAN; INFECTION RISK; INFLAMMATION; LEUKOPENIA; MODEL; MOUTH FLORA; MOUTH HYGIENE; MUCOSA INFLAMMATION; NONHUMAN; NUTRITIONAL STATUS; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SALIVARY GLAND; SEX DIFFERENCE; STOMATITIS; THROMBOCYTOPENIA; WHOLE BODY RADIATION; WOUND HEALING IMPAIRMENT;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; MOUTH MUCOSA; NUTRITIONAL STATUS; RISK FACTORS; STOMATITIS;

EID: 0037294291     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(02)00033-7     Document Type: Review

References (83)

1. Carl W. Bone marrow transplant and oral complications. Quintessence Intl. 10:1984;1001-1009.
2. Mattsson T., Heimdahl A., Dahlof G., Nilsson B., Lonnqvist B., Ringden O. Variables predicting oral mucosal lesions in allogeneic bone marrow recipients. Head Neck. 13:1991;224-229.
3. McCarthy G.M., Awde J.D., Ghandi H., Vincent M., Kocha W.I. Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol. 34:1998;484-490.
4. Peterson D.E. Toxicity of chemotherapeutic agents. Semin Oncol. 19:1991;478-491.
5. Peterson D.E., Sonis S.T. Oral complications of cancer chemotherapy. Devel Oncol. 12:1983;801-818.
6. Seto B.G., Kim M., Wolinsky L., Mito R.S., Champlin R. Oral mucositis in patients undergoing bone marrow transplantation. Oral Surg Oral Med Oral Pathol. 53:1985;32-36.
7. Wilkes J.D. Prevention and treatment of oral mucositis following cancer chemotherapy. Semin Oncol. 25:1998;538-551.
8. Consensus development conference on oral complications of cancer therapies: Diagnosis, prevention, and treatment. NCI Monogr 1990;9.
9. Sonis S.T. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol, 34:1998;39-43.
10. Barasch A., Safford M.M., Eisenberg E. Oral cancer and oral effects of anticancer therapy. Mount Sinai J Med. 65:1998;370-377.
11. Verdi C.J. Cancer therapy and oral mucositis: an appraisal of drug prophylaxis. Drug Saf. 9:1993;185-195.
12. Schubert M.M., Williams B.E., Lloid M.E., Donaldson G., Chapko M.K. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Cancer. 69:1992;2469-2477.
13. Woo S.B., Sonis S.T., Monopoli M.M., Sonis A.L. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer. 72:1993;1612-1617.
14. Ahmed T., Engelking C., Szalyga J., Helson L., Coombe L., Cook P.et al. Propantheline prevention of mucositis from etoposide. Bone Marrow Transplant. 12:1993;131-132.
15. Bondi E., Baroni C., Prete A., Gatti M., Carrassi A., Lodi G.et al. Local antimicrobial therapy of oral mucositis in paediatric patients undergoing bone marrow transplantation. Oral Oncol. 33:1997;322-326.
16. Brown A.T., Shupe A.J., Sims E.R. In vitro effect of chlorhexidine and amikacin on oral gram negative bacilli from bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol. 70:1990;715-719.
17. Chiara S., Nobile N.T., Sanguineti O., Cognein P., Rosso R. Oral mucositis in advanced colorectal cancer patients receiving continuous 5-fluorouracil (5-FU) infusions (c.i.)+oral leukovorin (L-LV). Supp Care Cancer. 4:1996;238. (abstract).
18. Dodd M.J., Larson P.J., Dibble S.L., Miaskowski C., Greenspan D., MacPhail L.et al. Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncol Nurs Forum. 23:1996;921-927.
19. Duenas-Gonzalez A., Sobrevilla-Calvo P., Frias-Mendivil M., Gallardo-Rincon D., Lara-Medina F., Aguilar-Ponce M.et al. Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis: a randomized, double-blind study. Bone Marrow Transplant. 17:1996;809-812.
20. Elzawawy A. Treatment of 5-fluorouracil-induced stomatitis by allopurinol mouthwashes. Oncol. 48:1991;282-284.
21. Epstein J.B., Stevenson-Moore P., Jackson S., Mohamed J.H., Spinelli J.J. Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse. Int J Radiat Oncol Biol Phys. 116:1989;1571-1575.
22. Epstein J.B., Vickars L., Spinelli J., Reece D. Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation. Oral Surg Oral Med Oral Pathol. 73:1992;682-689.
23. Farell C.L., Bready J.V., Rex K.L. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res. 58:1998;933-939.
24. Feber T. Management of mucositis in oral irradiation. Clin Oncol R Coll Radiol. 8:1996;106-111.
25. Feld R. The role of surveillance culture in patients likely to develop chemotherapy-induced mucositis. Support Care Cancer. 5:1997;371-375.
26. Ferreti G.A., Ash R.C., Brown A.T., Parr M.D., Romond E.H., Lillich T.T. Chlorhexidine for prophylaxis of infections and associated complications in bone marrow transplant patients. J Am Dent Assoc. 114:1987;461-467.
27. Ferretti G.A., Raybould T.P., Brown A.T., MacDonald J.S., Greenwood M., Maruyama Y.et al. Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial. Oral Surg Oral Med Oral Pathol. 69:1990;331-338.
28. Foote R.L., Loprinzi C.L., Frank A.R., O'Fallon J.R., Gulavita S., Tewfik H.H.et al. Randomized trial of chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J Clin Oncol. 12:1994;2630-2633.
29. Gordon B., Spadinger A., Hodges E., Ruby E., Stanley R., Coccia P. Effect of granulocyte-macrophage colony stimulating factor on oral mucositis after hematopoietic stem cell transplantation. J Clin Oncol. 12:1994;1917-1922.
30. Ibrahim E.M., al-Mulhim F.A. Effects of granulocyte-macrophage colony stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients. Med Oncol. 14:1997;47-51.
31. Jebb S.A., Osborne R.J., Maughan T.S., Mohideen N., Mak P., Mort D.et al. Five-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation. Br J Cancer. 70:1994;732-735.
32. Karthaus M., Rosenthal C., Huebner G. Effect of topical granulocite colony stimulating factor on oral mucositis: a randomized, placebo-controlled trial. Bone Marrow Transplant. 22:1998;781-785.
33. Kim J.H., Chu F.C., Lakshmi V., Houde R. Benzydamine HCl, a new agent for the treatment of radiation mucositis of the oropharynx. Am J Clin Oncol. 9:1986;132-134.
34. Labar B., Mrsic M., Pavletic Z., Bogdanic V., Nemet D., Aurer I.et al. Prostaglandin E2 for prophylaxis of oral mucositis following bone marrow transplantation. Bone Marrow Transplant. 11:1993;379-382.
35. Leborgne J.H., Leborgne F., Zubizarreta E., Ortega B., Mezera J. Corticosteroids and radiation mucositis in head and neck cancer: a double blind, placebo-controlled, randomized study. Radiother Oncol. 47:1998;145-148.
36. Lever S.A., Dupuis L.L., Chan S.L. Comparative evaluation of benzydamine oral rinse in children with antineoplastic-induced stomatitis. Drug Intel Clin Pharm. 21:1987;359-361.
37. Lieschke G.J., Ramenghi U., O'Conner M.P., Sheriden W., Szer J., Morstyn J. Studies of oral neutrophil levels in patients receiving granulocyte colony stimulating factor after autologous bone marrow transplantation. Br J Haematol. 82:1992;589-595.
38. Loprinzi C.L., Cianflone S.G., Dose A.M., Etzell P.S., Burnham N.L., Fischer T.et al. A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis. Cancer. 65:1990;1879-1882.
39. Mascarin M., Franchin G., Minatel E., Gobitti C., Talamini R., De Maria D.et al. The effect of granulocyte colony-stimulating factor on oral mucositis in head and neck cancer patients treated with hyperfractionated radiotherapy. Oral Oncol. 35:1999;203-208.
40. McGaw W.T., Belch A. Oral complications of acute leukemia: prophylactic impact of chlorhexidine mouth rinse regimen. Oral Surg Oral Med Oral Pathol. 60:1985;275-280.
41. Ning S., Shui C., Khan W.B. Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo. Int J Rad Oncol Biol Phys. 40:1998;177-187.
42. Oblon D.J., Paul S.R., Oblon M.B., Malik S. Propantheline protects the oral mucosa after high-dose ifosfamide, carboplatin, etoposide and autologous stem cell transplantation. Bone Marrow Transplant. 20:1997;961-963.
43. Okuno S.H., Foote R.L., Loprinzi C.L., Gulavita S., Sloan J.A., Earle J.et al. A randomized trial of a non-absorbable antibiotic lozenge given to alleviate radiation-induced mucositis. Cancer. 79:1997;2193-2199.
44. Prada A., Chiesa F. Effects of benzydamine on the oral mucositis during antineoplastic radiotherapy and/or intra-arterial chemotherapy. Int J Tiss Reac. 9:1987;115-119.
45. Rutkauskas J.S., Davis J.W. Effects of chlorhexidine during immunosuppressive chemotherapy: a preliminary report. Oral Surg Oral Med Oral Pathol. 76:1993;441-448.
46. Samaranayake L.P., Robertson A.G., MacFarlane T.W., Hunter I.P., MacFarlane G., Soutar D.S.et al. The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation. Clin Radiol. 39:1988;291-294.
47. Schubert M.M., Newton R.E. The use of benzydamine HCl for the management of cancer therapy-induced mucositis: preliminary report of a multicentre study. Int J Tiss Reac. 9:1987;99-103.
48. Scubitz K.M., Anderson P.M. Oral glutamine to prevent chemotherapy-induced stomatitis: a pilot study. J Lab Clin Med. 127:1996;223-228.
49. Spijkervet F.K.L., van Saene H.K.F., Panders A.K., Vermey A., van Saene J.J.M., Mehta D.M.et al. Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis. Oral Surg Oral Med Oral Pathol. 67:1989;154-161.
50. Spijkervet F.K.L., van Saene H.K.F., van Saene J.J.M., Panders A.K., Vermey A., Mehta D.M.et al. Effects of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients. J Surg Oncol. 46:1991;167-173.
51. Sonis S.T., Costa J.W., Evitts S.M., Lindquist L.E., Nicolson M. Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy. Oral Surg Oral Med Oral Pathol. 74:1992;749-755.
52. Symonds R.P., McIlroy P., Khorrami J., Paul J., Pyper E., Alcock E.et al. The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled, double-blind trial. Br J Cancer. 74:1996;312-317.
53. Tsavaris N.B., Konistopoulou P., Tzanou I. Decreased oral toxicity with the local use of allopurinol in patients who received high-dose 5-florouracil. Sel Cancer Ther. 7:1991;113-117.
54. van Zaanen H.C.T., van der Lelie H., Timmer J.G., Furst P., Sauerwein H. Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity. Cancer. 74:1994;2879-2884.
55. Wahlin B.Y. Effects of chlorhexidine mouth rinse on oral health in patients with acute leukemia. Oral Surg Oral Med Oral Pathol. 68:1989;279-287.
56. Weisdorf D.J., Bostrom B., Rather D., Mattingly M., Walker P., Pihlstrom B.et al. Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse. Bone Marrow Transplant. 4:1989;89-95.
57. Peterson D.E. Pretreatment strategies for infection prevention in chemotherapy patients. NCI Monogr. 9:1990;61-71.
58. Squier C.A. Mucosal alterations. NCI Monogr. 9:1990;169-172.
59. Lockhart P.B., Sonis S.T. Relationship of oral complications to peripheral blood leukocyte and platelet counts in patients receiving cancer chemotherapy. Oral Surg Oral Med Oral Pathol. 48:1979;210-218.
60. Sonis S.T., Sonis A.L., Lieberman A. Oral complications in patients receiving treatment for malignancy other than the head and neck. J Am Dent Assoc. 97:1978;476-482.
61. Chi K.W., Chen C.H., Chan W.K., Chow C.K., Chen S.Y., Yen S.H.et al. Effect of granulocyte-macrophage colony stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil and leukovorin chemotherapy. J Clin Oncol. 13:1995;2620-2628.
62. Zalcberg J., Kerr D., Seymour L., Palmer M. Hematological and non-hematological toxicity after 5-florouracil and leukovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number. Eur J Cancer. 34:1998;1871-1875.
63. Sonis S.T., Lindquist L., van Vught A.G., Stewart A.A., Stam K., Qu G.Y.et al. Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3. Cancer Res. 54:1994;1135-1138.
64. Sonis S.T., van Vught A.G., Brien J.P.O., Muska A.D., Bruskin A.M., Rose A.et al. Transforming growth factor beta 3-mediated modulation of cell cycling and attenuation of 5-florouracil-induced oral mucositis. Oral Oncol. 33:1997;47-54.
65. Sonis S.T., van Vught A.G., McDonald J., Dotoli E., Schwertschlag U., Szklut P.et al. Mitigating effects of interleukin 11 on consecutive courses of 5-florouracil-induced ulcerative mucositis in hamsters. Cytokine. 9:1997;605-612.
66. Borowski B., Benhamov E., Pico J.L., Laplanche A., Margainaud J.P., Hayat M. Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomized, controlled trial comparing two protocols of dental care. Oral Oncol Eur J Cancer. 30B:1994;93-97.
67. Grosvenor A., Bulcavage I., Chelebowski R.T. Symptoms potentially influencing weight loss in a cancer population. Cancer. 63:1989;330-334.
68. Zerbe M.B., Parkerson S.G., Ortlieb M.L., Spitzer T. Relationship between oral mucositis and treatment variables in bone marrow transplant patients. Cancer Nurs. 15:1992;196-205.
69. Barasch A., Peterson D.E., Tanzer J.M., D'Ambrosio J.A., Nuki K., Schubert M.M.et al. Helium-neon laser efects on conditioning-induced oral mucositis in bone marrow transplant patients. Cancer. 76:1995;2250-2256.
70. Wingard J.R., Niehaus C.S., Peterson D.E., Jones R.J., Piantadosi S., Levin L.S.et al. Oral mucositis after bone marrow transplantation. Oral Surg Oral Med Oral Pathol. 72:1991;419-424.
71. Muller S., Yeager K.A., Hodgson-Woodruff N., Peterson D.E., McGuire D.S. Factors influencing the development and severity of oral mucositis in bone marrow and stem cell transplant patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 87:1991;458. (abstr.).
72. Raber-Durlacher J.E. Current practices for management of oral mucositis in cancer patients. Support Care Cancer. 7:1991;71-74.
73. Anderson P.M., Schroeder G., Skubitz K.M. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic chemotherapy. Cancer. 83:1998;1433-1439.
74. Cohen G., Elad S., Or R., Galili D., Garfunkel A.A. The use of tretinoin as oral mucosatis prophylaxis in bone marrow transplant patients: A preliminary study. Oral Dis. 3:1997;243-246.
75. Wadleigh R.G., Redman R.S., Graham M.L.et al. Vitamin E in the treatment of chemotherapy-induced oral mucositis. Am J Med. 92:1992;481-484.
76. Adamietz I.A., Rahn R., Bottcher H.D.et al. Prophylaxis with providone-iodine against induction of oral mucositis by radiochemistry. Support Care Cancer. 6:1998;373-377.
77. Petit RG. Phase III clinical trial design considerations for oral treatment of chemotherapy-induced mucositis: AES 14 (uptake-facilitated L-glutamine) pivotal studies. Proc Am Soc Clin Oncol, 2001;301b(abstr).
78. Loury D.J., Embree J.R., Steinberg D.A., Sonis S.T., Fiddes J.C. Effect of the local application of the antimicrobial peptide IB 367 on the incidence and severity of oral mucositis in hamsters. Oral Surg Oral Med Oral Pathol Radiol Endod. 87:1999;544-551.
79. Abdelaal A.S., Barker D.S., Fergusson M.M. Treatment for irradiation-induced mucositis. Lancet. 1:1989;97(letter).
80. Slavik M., Wu J., Riley C. Salivary excretion of anticancer drugs. Proc Am Soc Clin Oncol. 7:1988;319-321.
81. Verdi C.J., Garewal H.S., Koenig M.L., Vaughn B., Barkhead T. A double-blind, randomized, placebo-controlled, cross-over trial of pentoxifyline for the prevention of chemotherapy-induced oral mucositis. Oral Surg Oral Med Oral Pathol Radiod Endod. 80:1995;36-42.
82. Antman K.S., Griffin J.D., Elias A.et al. Effects of recombinant human granulocyte-macrophage colony stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med. 319:1988;593-598.
83. Harris M.I., Eastman R., Cowie C.C., Flegal K.M., Eberhardt M.S. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care. 22:1999;403-408.